Idera Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Cambridge MA United States (1989)

Organization Overview

First Clinical Trial
2004
NCT00729053
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Idera Pharmaceuticals | Idera Pharmaceuticals, Inc.